First human tests begin for experimental drug UCB5285

NCT ID NCT07286682

Recruiting now Knowledge-focused Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study to check if a new drug called UCB5285 is safe for people and how the body handles it. Healthy volunteers will receive either the drug or a placebo (inactive substance) in increasing doses. Researchers will monitor for side effects and measure how long the drug stays in the bloodstream.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

Up0161 1001
RECRUITING

Harrow, United Kingdom

Conditions

Explore the condition pages connected to this study.

HEALTHY PARTICIPANTS